Emergent Biosolutions reported $365.4M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Akebia Therapeutics AKBA:US $ 189.2M 23.61M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amarin AMRN:US $ 364.74M 5.69M
Ani Pharmaceuticals ANIP:US $ 84.87M 4.58M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Chimerix CMRX:US $ 26.29M 1.37M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Emergent Biosolutions EBS:US $ 365.4M 12.4M
Exact Sciences EXAS:US $ 710.23M 34.53M
Exelixis EXEL:US $ 269.51M 14.18M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Glaxosmithkline GSK:US $ 22417M 1030M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Immunogen IMGN:US $ 111.78M 8.53M
Ironwood Pharmaceuticals IRWD:US $ 145.69M 11.32M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Lonza Group LONN:SW 3.11B 12M
Moderna Inc MRNA:US 9.96B 1.12B
Myriad Genetics MYGN:US $ 203.2M 67.8M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Opko Health OPK:US $ 283.04M 20.94M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
United Therapeutics UTHR:US $ 320M 8.6M
Vanda Pharmaceuticals VNDA:US $ 72M 0.01M
Xoma XOMA:US $ 6.51M 221K